Extracorporeal Membrane Oxygenation (ECMO): Blood Cells

Corewell Health West371 enrolled

Overview

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

Study Type

OBSERVATIONAL

Enrollment

371

Conditions

Extracorporeal Membrane Oxygenation

Interventions

Blood specimen collectionOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

ECMO group: Inclusion Criteria: * Greater than or equal to 18 years of age * Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy. Exclusion Criteria: * Subject is less than 18 years of age * Known prisoner Control Subjects: Inclusion Criteria * Greater than 18 years of age * Without any known cardiovascular, lung, or autoimmune disease. Exclusion Criteria: * Less than or equal to 18 years of age * Known cardiovascular, lung, or autoimmune disease

Locations (1)

Spectrum Health

Grand Rapids, Michigan, United States

Outcomes

Primary Outcomes

All cause mortality

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.